AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 229 filers reported holding AMICUS THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $22,778,000 | -56.3% | 2,305,432 | +2.1% | 0.12% | -52.5% |
| Q4 2020 | $52,131,000 | +77.1% | 2,257,751 | +8.3% | 0.26% | +43.1% |
| Q3 2020 | $29,437,000 | -8.2% | 2,084,742 | -2.0% | 0.18% | -27.9% |
| Q2 2020 | $32,068,000 | +17048.7% | 2,126,511 | +14076.7% | 0.25% | +12450.0% |
| Q2 2019 | $187,000 | -96.5% | 15,000 | -96.1% | 0.00% | -97.6% |
| Q3 2015 | $5,340,000 | -30.2% | 381,695 | -29.4% | 0.08% | -15.0% |
| Q2 2015 | $7,648,000 | – | 540,524 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |